Maximum A Posteriori Bayesian Estimation of Mycophenolic Acid Area Under the Concentration-Time Curve: Is This Clinically Useful for Dosage Prediction Yet? Christine E. StaatzSusan E. Tett Review Article 13 September 2012 Pages: 759 - 772
Kinetic Nomograms Assist Individualization of Drug Regimens Hafedh MarouaniAnastasios ZografidisAthanassios Iliadis Original Research Article 13 September 2012 Pages: 773 - 779
Effect of Cytochrome P450 3A4 Inducers on the Pharmacokinetic, Pharmacodynamic and Safety Profiles of Bortezomib in Patients with Multiple Myeloma or Non-Hodgkin’s Lymphoma Andrzej HellmannSimon RuleVernon J. Louw Original Research Article 13 September 2012 Pages: 781 - 791
Population Pharmacokinetic Meta-Analysis of Denosumab in Healthy Subjects and Postmenopausal Women with Osteopenia or Osteoporosis Liviawati SutjandraRachelle D. RodriguezJuan José Pérez-Ruixo Original Research Article 13 September 2012 Pages: 793 - 807
Application of a Systems Approach to the Bottom-Up Assessment of Pharmacokinetics in Obese Patients Cyrus GhobadiTrevor N. JohnsonAmin Rostami-Hodjegan Original Research Article 13 September 2012 Pages: 809 - 822
Population Pharmacokinetic/Pharmacodynamic Analyses as the Basis for Dosing of Therapeutic Monoclonal Antibodies Bernd Meibohm Commentary 13 September 2012 Pages: 823 - 824
Obesity and Its Impact on Drug Therapy Michael NeelyStan Louie Commentary 13 September 2012 Pages: 825 - 826
Erratum to: Pharmacokinetics of antimalarials in pregnancy: a systematic review K. J. WilbyM. H. H. Ensom Erratum 13 September 2012 Pages: 827 - 827